Health Care Blog » Biopharmaceutical

ShareVault For Biopharmaceutical Licensing

Admin — Tue, 25 Jan 2011 03:10:20 +0000

ShareVault™ is the ideal virtual data room solution for accelerating due diligence associated with biopharmaceutical partnering, including business development, out-licensing, in-licensing, technology transfer and partner development.

Accelerate your due diligence

Due diligence timelines are tight, so you don’t want to be hampered by a slow, clunky virtual data room. ShareVault is built for speed, so it can keep pace with your demanding requirements.

Reach more partners

Your documents are securely accessible on-line from any web-browser, with consistent ease-of-use, allowing you to cast a broader net early in your business development process.

Secure your documents online

Your information is safe due to ShareVault’s™ bank-grade reliability and security functionality.

Protect your intellectual property

ShareVault’s™ advanced PDFtrak™ feature provides powerful document protection capabilities, and allows you to revoke document access rights even after a document has been downloaded.

Track the due diligence process

ShareVault’s™ advanced PDFtrak™ feature also provides detailed activity reporting so you know who’s accessed what and when.

Count on ShareVault’s 24-hour support

ShareVault™ is backed by a comprehensive support plan, including 24/7/36 support hotline, and a dedicated project manager.

.Reference resource: Click Here.

Biopharmaceutical Tubing Suits Custom Assembly Fabrications.

Admin — Mon, 24 Jan 2011 02:58:25 +0000

November 7, 2003 – SaniPureâ„¢-60 clear, flexible, tubing may be sealed, bonded, welded, and molded with heat. Smooth inner bore reduces particle entrapment and microscopic build-up, and facilitates complete sanitation of fluid transfer. Fully autoclavable and sterilizable product has absorption rate lower than elastomeric tubing. It also exhibits low protein binding characteristics, low permeability qualities, and is non-cytotoxic, non-pyrogenic, and non-hemolytic.

Reference resource: Click Here.

Multinational Biopharmaceutical Company

Admin — Wed, 16 Jan 2008 09:51:06 +0000

Celgene, the U.S multinational biopharmaceutical company, was founded in 1980. Its goal is to build a major global biopharmaceutical corporation focused on discovering, developing and commercializing innovative therapies to treat cancer and inflammation through gene and protein regulation. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene’s operations are now spread throughout the U.S as a globally integrated and culturally diverse biopharmaceutical company with more than 1,600 employees worldwide.